BIOMERICA INC — Investor Relations & Filings
Filings indexed
587
across all filing types
Latest filing
2026-06-04
Capital/Financing Update
Country
US
United States of America
Listing
US
BMRA
Biomerica, Inc. is a global biomedical technology company that develops, patents, manufactures, and markets advanced in-vitro diagnostic (IVD) and therapeutic products. The company provides solutions for both laboratory and at-home testing, designed for the early detection and monitoring of chronic conditions. Its primary research and development focus is on gastrointestinal and inflammatory diseases, with a notable pipeline that includes a non-drug, diagnostic-guided therapy for Irritable Bowel Syndrome (IBS). Biomerica's products aim to enhance patient health and well-being while contributing to the reduction of total healthcare costs.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K | 2026-06-04 | English | |
| 10-Q - BIOMERICA INC (0000073290) (Filer) | 2026-04-13 | English | |
| S-8 | 2026-02-27 | English | |
| 4 Filing | 2026-01-28 | English | |
| 10-Q Filing | 2026-01-14 | English | |
| 4 Filing | 2025-12-31 | English |
Browse filings by year
32 years- 2026 5 filings
- 2025 19 filings
- 2024 23 filings
- 2023 50 filings
- 2022 18 filings
- 2021 27 filings
- 2020 44 filings
- 2019 19 filings
- 2018 43 filings
- 2017 18 filings
- 2016 50 filings
- 2015 19 filings
- 2014 9 filings
- 2013 9 filings
- 2012 16 filings
- 2011 16 filings
- 2010 10 filings
- 2009 14 filings
- 2008 20 filings
- 2007 22 filings
- 2006 15 filings
- 2005 18 filings
- 2004 16 filings
- 2003 15 filings
- 2002 10 filings
- 2001 10 filings
- 2000 8 filings
- 1999 15 filings
- 1998 11 filings
- 1997 10 filings
- 1996 6 filings
- 1995 2 filings
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
5 filings
| |||||
| 47971620 | 8-K | 2026-06-04 | English | ||
| 34442962 | 10-Q - BIOMERICA INC (0000073290) (Filer) | 2026-04-13 | English | ||
| 45988071 | S-8 | 2026-02-27 | English | ||
| 17048707 | 4 Filing | 2026-01-28 | English | ||
| 17048732 | 10-Q Filing | 2026-01-14 | English | ||
|
2025
10 filings
| |||||
| 17048733 | 4 Filing | 2025-12-31 | English | ||
| 17048715 | 4 Filing | 2025-12-31 | English | ||
| 17048714 | 4 Filing | 2025-12-31 | English | ||
| 17048706 | 4 Filing | 2025-12-31 | English | ||
| 17048694 | 4 Filing | 2025-12-31 | English | ||
| 17048727 | 8-K Filing | 2025-12-16 | English | ||
| 8636515 | DEFA14A | 2025-10-23 | English | ||
| 8636519 | DEF 14A | 2025-10-20 | English | ||
| 8636522 | 10-Q | 2025-10-14 | English | ||
| 9159988 | PRE 14A | 2025-10-09 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Ajanta Pharma Ltd.
Specialty pharmaceutical firm focused on complex generics a…
|
AJANTPHARM | IN | Manufacturing |
|
Akari Therapeutics Plc
Develops next-gen antibody-drug conjugates using proprietar…
|
AKTX | US | Manufacturing |
|
Akebia Therapeutics, Inc.
A biopharmaceutical company that develops and commercialize…
|
AKBA | US | Manufacturing |
|
Akeso, Inc.
Global commercial-stage biopharma developing innovative ant…
|
9926 | KY | Manufacturing |
|
Aktis Oncology, Inc.
A clinical-stage biotech developing targeted alpha radiopha…
|
AKTS | US | Manufacturing |
|
Akums Drugs and Pharmaceuticals Limited
CDMO providing end-to-end pharmaceutical manufacturing and …
|
AKUMS | IN | Manufacturing |
|
Albert David Ltd.
Produces pharmaceutical formulations, infusions, and specia…
|
ALBERTDAVD | IN | Manufacturing |
|
Aldeyra Therapeutics, Inc.
Develops medications for immune-mediated ocular and systemi…
|
ALDX | US | Manufacturing |
|
Aleafia Health Inc.
Vertically integrated cannabis company with cultivation, pr…
|
AH | CA | Manufacturing |
|
Alector, Inc.
Clinical-stage biotech using immuno-neurology to treat neur…
|
ALEC | US | Manufacturing |
BIOMERICA INC via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/35296/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=35296 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=35296 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=35296 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 35296}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for BIOMERICA INC (id: 35296)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.